• American heart journal · May 2010

    Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative.

    • Shahyar Michael Gharacholou, Karen P Alexander, Anita Y Chen, Tracy Y Wang, Chiara Melloni, W Brian Gibler, Charles V Pollack, E Magnus Ohman, Eric D Peterson, and Matthew T Roe.
    • Duke Clinical Research Institute, Durham, NC, USA.
    • Am. Heart J. 2010 May 1;159(5):757-63.

    BackgroundPrompt reperfusion for patients with ST-segment elevation myocardial infarction (STEMI) is a class I guideline recommendation and has been shown to reduce mortality. However, many STEMI patients in contemporary practice still do not receive any form of reperfusion therapy.MethodsWe evaluated 8,578 patients with STEMI from 226 US hospitals participating in the CRUSADE quality improvement initiative from September 2004 to December 2006 to determine the proportion of eligible patients who received an attempt at reperfusion therapy and factors associated with lack of reperfusion among patients without a contraindication to reperfusion. STEMI patients were classified into 3 groups: (1) patients eligible for reperfusion and for whom reperfusion was attempted; (2) patients eligible for reperfusion and for whom reperfusion was not attempted; and (3) patients who were ineligible for reperfusion because of identified contraindications. We compared patient characteristics, treatments, and outcomes among the groups and identified factors independently associated with lack of reperfusion use among eligible patients.ResultsOf the 8,578 patients with STEMI, 881 patients (10.3%) had a documented contraindication to reperfusion, 7,080 (82.5%) received fibrinolysis or underwent an attempt at primary percutaneous coronary intervention, and 617 reperfusion-eligible patients (7.2%) had no attempt to administer reperfusion. Primary reasons for contraindications were identified as absence of an ischemic indication (n = 474; 53.8%), bleeding risk (n = 147; 16.7%), patient-related reasons (n = 223; 25.3%), and other (n = 37; 4.2%). The strongest factors associated with not attempting reperfusion among the reperfusion-eligible population were older age, heart failure at presentation, noncardiac surgical center, prior stroke, and female sex. Compared with patients receiving an attempt at reperfusion, adjusted in-hospital mortality rates were higher for patients with a documented reperfusion contraindication (adjusted odds ratio 1.77, 95% CI 1.28-2.45) and in eligible patients who did not receive reperfusion (adjusted odds ratio 1.64, 95% CI 1.07-2.50).ConclusionsMore than 7% of STEMI patients without a reperfusion contraindication did not have an attempt to administer reperfusion therapy, and this was associated with greater in-hospital mortality. Age, sex, and comorbidity were factors related to lack of attempting reperfusion among apparently eligible patients. Quality improvement efforts should focus on maximizing reperfusion use among all eligible STEMI patients and in addressing the processes by which contraindications are defined, clinically determined, and reported.2010 Mosby, Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.